
Niloofar Rahmani
Examiner (ID: 12602, Phone: (571)272-4329 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1691, 1621 |
| Total Applications | 2303 |
| Issued Applications | 1739 |
| Pending Applications | 128 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17569880
[patent_doc_number] => 11318134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-03
[patent_title] => Benzamide compounds
[patent_app_type] => utility
[patent_app_number] => 16/957861
[patent_app_country] => US
[patent_app_date] => 2019-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 7
[patent_no_of_words] => 42981
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 413
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16957861
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/957861 | Benzamide compounds | Jan 7, 2019 | Issued |
Array
(
[id] => 18202363
[patent_doc_number] => 11584745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Aromatic heterocyclic compound, intermediate thereof, preparation method therefor, and pharmaceutical composition and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/964531
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16877
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1039
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964531
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/964531 | Aromatic heterocyclic compound, intermediate thereof, preparation method therefor, and pharmaceutical composition and use thereof | Dec 27, 2018 | Issued |
Array
(
[id] => 16885279
[patent_doc_number] => 20210171474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/958511
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 163495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958511
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/958511 | Glycolate oxidase inhibitors for the treatment of disease | Dec 27, 2018 | Issued |
Array
(
[id] => 18412036
[patent_doc_number] => 11666563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => Pharmaceutical preparation containing pyridyl aminoacetic acid compound
[patent_app_type] => utility
[patent_app_number] => 16/957749
[patent_app_country] => US
[patent_app_date] => 2018-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7848
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16957749
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/957749 | Pharmaceutical preparation containing pyridyl aminoacetic acid compound | Dec 26, 2018 | Issued |
Array
(
[id] => 17620122
[patent_doc_number] => 11339158
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Crystalline form of valbenazine ditosylate, processes for preparation thereof and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/771799
[patent_app_country] => US
[patent_app_date] => 2018-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 6636
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16771799
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/771799 | Crystalline form of valbenazine ditosylate, processes for preparation thereof and use thereof | Dec 25, 2018 | Issued |
Array
(
[id] => 16374370
[patent_doc_number] => 20200323212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => PEST CONTROL COMPOSITION AND USE OF SAME
[patent_app_type] => utility
[patent_app_number] => 16/957554
[patent_app_country] => US
[patent_app_date] => 2018-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16957554
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/957554 | PEST CONTROL COMPOSITION AND USE OF SAME | Dec 24, 2018 | Abandoned |
Array
(
[id] => 17274345
[patent_doc_number] => 20210380543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => SOLID STATE FORMS OF PEMAFIBRATE
[patent_app_type] => utility
[patent_app_number] => 16/957179
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16957179
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/957179 | Solid state forms of Pemafibrate | Dec 20, 2018 | Issued |
Array
(
[id] => 18215199
[patent_doc_number] => 11590112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Methods and compounds for the treatment or prevention of hypercytokinemia and severe influenza
[patent_app_type] => utility
[patent_app_number] => 16/957063
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 23
[patent_no_of_words] => 21367
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16957063
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/957063 | Methods and compounds for the treatment or prevention of hypercytokinemia and severe influenza | Dec 19, 2018 | Issued |
Array
(
[id] => 17922741
[patent_doc_number] => 11465974
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Crystalline polymorphs of Pracinostat and Pracinostat salts
[patent_app_type] => utility
[patent_app_number] => 16/954227
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 11563
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16954227
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/954227 | Crystalline polymorphs of Pracinostat and Pracinostat salts | Dec 18, 2018 | Issued |
Array
(
[id] => 17822642
[patent_doc_number] => 11427580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => 6-azaindole compounds
[patent_app_type] => utility
[patent_app_number] => 16/955089
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30960
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955089
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955089 | 6-azaindole compounds | Dec 17, 2018 | Issued |
Array
(
[id] => 17620125
[patent_doc_number] => 11339161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Triazolo pyridines as modulators of gamma-secretase
[patent_app_type] => utility
[patent_app_number] => 16/955093
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22215
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955093
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955093 | Triazolo pyridines as modulators of gamma-secretase | Dec 17, 2018 | Issued |
Array
(
[id] => 16711813
[patent_doc_number] => 20210078960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => CRYSTAL AND SALT OF 4-(NAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOLE COMPOUND AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/772300
[patent_app_country] => US
[patent_app_date] => 2018-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16772300
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/772300 | Crystal and salt of 4-(naphthalen-1-yl)-4H-1,2,4-triazole compound and preparation method therefor | Dec 16, 2018 | Issued |
Array
(
[id] => 16512875
[patent_doc_number] => 20200392133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => AZAINDOLE DERIVATIVES AS RHO- KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/954977
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16954977
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/954977 | Azaindole derivatives as Rho-kinase inhibitors | Dec 13, 2018 | Issued |
Array
(
[id] => 16870005
[patent_doc_number] => 20210163472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => CHEMICAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/770673
[patent_app_country] => US
[patent_app_date] => 2018-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770673
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770673 | Chemical compounds | Dec 11, 2018 | Issued |
Array
(
[id] => 18329188
[patent_doc_number] => 11634416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridines
[patent_app_type] => utility
[patent_app_number] => 16/772561
[patent_app_country] => US
[patent_app_date] => 2018-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44059
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 547
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16772561
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/772561 | Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridines | Dec 11, 2018 | Issued |
Array
(
[id] => 16452487
[patent_doc_number] => 20200361913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => SALT FORM AND CRYSTAL FORM SERVING AS FGFR AND VEGFR INHIBITOR COMPOUNDS, AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/770196
[patent_app_country] => US
[patent_app_date] => 2018-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770196
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770196 | Salt form and crystal form serving as FGFR and VEGFR inhibitor compounds, and preparation method therefor | Dec 6, 2018 | Issued |
Array
(
[id] => 14156409
[patent_doc_number] => 20190105307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT
[patent_app_type] => utility
[patent_app_number] => 16/212360
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16212360
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/212360 | Compounds and compositions for the inhibition of NAMPT | Dec 5, 2018 | Issued |
Array
(
[id] => 14438815
[patent_doc_number] => 20190177279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => CARBOXYLIC ACID AROMATIC 1,2-CYCLOPROPYLAMIDES
[patent_app_type] => utility
[patent_app_number] => 16/211486
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37505
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16211486
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/211486 | CARBOXYLIC ACID AROMATIC 1,2-CYCLOPROPYLAMIDES | Dec 5, 2018 | Abandoned |
Array
(
[id] => 17407121
[patent_doc_number] => 11247990
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-02-15
[patent_title] => Bicyclic fused pyridine compounds as inhibitors of TAM kinases
[patent_app_type] => utility
[patent_app_number] => 16/893784
[patent_app_country] => US
[patent_app_date] => 2018-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81461
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1008
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16893784
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/893784 | Bicyclic fused pyridine compounds as inhibitors of TAM kinases | Dec 4, 2018 | Issued |
Array
(
[id] => 14551113
[patent_doc_number] => 10343997
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-07-09
[patent_title] => Ursolic acid derivatives
[patent_app_type] => utility
[patent_app_number] => 16/208849
[patent_app_country] => US
[patent_app_date] => 2018-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3687
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16208849
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/208849 | Ursolic acid derivatives | Dec 3, 2018 | Issued |